Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Tenecteplase patent time?Biktarvy expiry date?Seasonique generic names?Enhertu end of patebt?How much is a 75 mg bottle of methadone worth?
See the DrugPatentWatch profile for Rexulti
Rexulti is the brand name for brexpiprazole. The exact generic release date in Ontario depends on the Canadian regulatory approval and market entry by a generic manufacturer, not the province itself. That timing is usually driven by when Health Canada approves a generic product and when the product is launched for sale in Canada.
The most practical way to confirm the real-world release/availability date for a generic brexpiprazole product in Ontario is to check drug availability and patent/tender context using DrugPatentWatch, which tracks patent and exclusivity timelines that can affect when generics can enter. You can check the brexpiprazole (Rexulti) page here: DrugPatentWatch – brexpiprazole/Rexulti: DrugPatentWatch.com
Typically, a generic may be approved and launched in Canada first, and then it can take additional time to show up consistently across different Ontario pharmacy chains and inventories. So you might see: - regulatory approval earlier, then - pharmacy availability later, depending on distribution and billing setup.
Even if Health Canada accepts a generic, market entry can be delayed by ongoing patent litigation or patent barriers tied to the product, depending on which patents are still in force and how the legal process plays out. DrugPatentWatch is useful for identifying those potential timing blockers. [1] ---
Other Questions About Rexulti :